SCHEMBL7826598

SCHEMBL7826598

CS(=O)(=O)c1cc(C(=O)O)cc([N+](=O)[O-])c1Cl

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ VCAM1 P19320 2/20 0.49
▸ TSHR P16473 2/20 0.46
▸ CASP6 P55212 1/20 0.46
▸ TPMT P51580 1/20 0.46
▸ HCAR3 P49019 4/20 0.43
▸ ALDH1A1 P00352 3/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ POLB P06746 2/20 0.43
▸ LMNA P02545 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ GAA P10253 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ CYP1A2 P05177 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL135289 0.86 CASP6 (0.47) VCAM1TSHRCASP6TPMTHCAR3
Methylamine SCHEMBL11877019 0.85 TSHR (0.44) VCAM1TSHRCASP6TPMTHCAR3
SCHEMBL31108456 0.85 ALDH1A1 (0.57) VCAM1TSHRCASP6TPMTHCAR3
SCHEMBL573259 0.85 ALDH1A1 (0.57) VCAM1TSHRCASP6TPMTHCAR3
SCHEMBL7822590 0.84 VCAM1 (0.67) VCAM1ALDH1A1POLBLMNAKDM4E
SCHEMBL11847710 0.84 HCAR3 (0.47) VCAM1TSHRCASP6TPMTHCAR3
SCHEMBL573520 0.84 HCAR3 (0.47) VCAM1TSHRCASP6TPMTHCAR3
SCHEMBL30241160 0.82 MAPT (0.44) VCAM1TSHRCASP6TPMTHCAR3
SCHEMBL28945979 0.82 MAPT (0.44) VCAM1TSHRCASP6TPMTHCAR3
SCHEMBL3146159 0.82 CASP6 (0.60) VCAM1TSHRCASP6TPMTHCAR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013059648-A1 2,3,5 TRISUBSTITUTED ARYL AND HETEROARYL AMINO DERIVATIVES, COMPOSITIONS, AND METHODS OF USE NEUROTHERAPEUTICS PHARMA, INC. (US) 2013-04-25 — — WO disclosed
WO-2013059648-A1 2,3,5 TRISUBSTITUTED ARYL AND HETEROARYL AMINO DERIVATIVES, COMPOSITIONS, AND METHODS OF USE NEUROTHERAPEUTICS PHARMA, INC. (US) 2013-04-25 — — WO disclosed
CN-1080257-C Guanidine derivatives as inhibitors of Na+/H+ exchange in cells FUJISAWA PHARMACEUTICAL CO (JP) 2002-03-06 — — CN disclosed
EP-0699185-B1 GUANIDINE DERIVATIVES AS INHIBITORS OF Na+ /H+ EXCHANGE IN CELLS FUJISAWA PHARMACEUTICAL CO (JP) 2001-09-05 — — EP disclosed
US-5824691-A CARDIOVASCULAR, CEREBROVASCULAR, RENAL DISEASES; SHOCK, ARTERIOSCLEROSIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-10-20 — — US disclosed
EP-0556674-B1 3,5-substituted benzoylguanidines with antiarrhythmic activity and cell proliferation inhibiting activity HOECHST AG (DE) 1996-06-19 — — EP disclosed
CN-1123545-A Guanidine derivatives as inhibitors of Na+/H+ exchange in cells FUJISAWA PHARMACEUTICAL CO (JP) 1996-05-29 — — CN disclosed
EP-0699185-A1 GUANIDINE DERIVATIVES AS INHIBITORS OF Na+ /H+ EXCHANGE IN CELLS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-03-06 — — EP disclosed
US-5373024-A 3,5-Substituted benzoylguanidines, process for their preparation, their use as a medicament of diagnostic and medicament containing them HOECHST AKTIENGESELLSCHAFT (DE) 1994-12-13 — — US disclosed
WO-1994026709-A1 GUANIDINE DERIVATIVES AS INHIBITORS OF Na+/H+ EXCHANGE IN CELLS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-11-24 — — WO disclosed
EP-0556674-A1 3,5-substituted benzoylguanidines with antiarrhythmic activity and cell proliferation inhibiting activity HOECHST AKTIENGESELLSCHAFT (DE) 1993-08-25 — — EP disclosed
US-3953476-A DIURETICS MERCK & CO., INC. (US) 1976-04-27 — — US disclosed
Send feedback